Advertisement
News
Advertisement

Agilent, Molecular Discovery join forces

Mon, 09/17/2012 - 10:13am

Agilent Technologies Inc. announced that it has entered into a comarketing agreement with Molecular Discovery Ltd. to provide biopharmaceutical researchers with an advanced metabolite-identification platform. The companies will comarket the combined assets of Agilent's high-resolution liquid chromatography/mass spectrometry (LC/MS) technology and Molecular Discovery's Mass-MetaSite software to enable superior identification and analysis of complex biological mixtures.

This comarketing program provides customers with a turnkey solution that bridges the gap between sophisticated laboratory software and hardware capabilities. The analytical benefits of Agilent's high-resolution instruments, integrated with Molecular Discovery's robust predictive metabolite-identification software tools, will advance drug research and discovery by enabling the decisive identification and conversion of large volumes of data into usable information.

Source: Agilent Technologies Inc.
Advertisement

Share This Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading